This Article  • PDF of this Correction  • Original article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 2007;125(11):1469.

Omission of Group in Byline and Clinical Trial Sites and Investigators. In the Clinical Trials article titled "Safety and Efficacy Assessment of Chimeric Ribozyme to Proliferating Cell Nuclear Antigen to Prevent Recurrence of Proliferative Vitreoretinopathy," published in the September 2007 issue of the Archives (2007;125[9]:1161-1167), "for the IM-VIT100 Study Group" was omitted from the byline. Also, the list of clinical trial sites and investigators was omitted and now appears in the online version of the article. The authors apologize for the oversight.